Quick Takeaways
- HBM Healthcare Investments (Cayman) Ltd. filed SCHEDULE 13G for Immuneering Corp Class A Common Stock, par value $0.001 per share (IMRX).
- Disclosed ownership: 5.7%.
- Date of event: 26 Sep 2025.
HBM Healthcare Investments (Cayman) Ltd. - 26 Sep 2025 SCHEDULE 13G Report for Immuneering Corp Class A Common Stock, par value $0.001 per share (IMRX)
- Filing Manager
- HBM Healthcare Investments (Cayman) Ltd.
- Reporting Manager
- HBM Healthcare Investments (Cayman) Ltd.
- Symbol
- IMRX
- Shares outstanding
- 63,970,246 shares
- Disclosed Ownership
- 3,646,304 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Oct 2025, 16:15:33 UTC
- Date of event
- 26 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"HBM Healthcare Investments (Cayman) Ltd. disclosed 5.7% ownership in Immuneering Corp Class A Common Stock, par value $0.001 per share (IMRX) on 26 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Oct 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. | 5.7% | 3,646,304 | 3,646,304 | 0 | /s/ Jean-Marc LeSieur | Jean-Marc LeSieur, Managing Director |